Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 190

1.

Specialty-Related Differences in the Acute-Phase Treatment and Prognosis in Patients With Acute Heart Failure - Insights From REALITY-AHF.

Kondo T, Okumura T, Matsue Y, Shiraishi A, Kagiyama N, Yamaguchi T, Kuroda S, Kida K, Mizuno A, Oishi S, Inuzuka Y, Akiyama E, Matsukawa R, Kato K, Suzuki S, Naruke T, Yoshioka K, Miyoshi T, Baba Y, Yamamoto M, Murai K, Mizutani K, Yoshida K, Kitai T, Murohara T.

Circ J. 2018 Dec 25;83(1):174-181. doi: 10.1253/circj.CJ-18-0724. Epub 2018 Nov 15.

2.

Dilated cardiomyopathy with re-worsening left ventricular ejection fraction.

Nabeta T, Inomata T, Ishii S, Yazaki M, Fujita T, Iida Y, Ikeda Y, Maekawa E, Naruke T, Koitabashi T, Ako J.

Heart Vessels. 2019 Jan;34(1):95-103. doi: 10.1007/s00380-018-1214-5. Epub 2018 Jun 25.

PMID:
29942977
3.

Importance of Early Diagnosis of Cardiac Sarcoidosis in Patients with Complete Atrioventricular Block.

Kaida T, Inomata T, Minami Y, Yazaki M, Fujita T, Iida Y, Ikeda Y, Nabeta T, Ishii S, Naruke T, Maekawa E, Koitabashi T, Ako J.

Int Heart J. 2018 Jul 31;59(4):772-778. doi: 10.1536/ihj.17-492. Epub 2018 May 23.

4.

Endothelial C-Type Natriuretic Peptide Acts on Pericytes to Regulate Microcirculatory Flow and Blood Pressure.

Špiranec K, Chen W, Werner F, Nikolaev VO, Naruke T, Koch F, Werner A, Eder-Negrin P, Diéguez-Hurtado R, Adams RH, Baba HA, Schmidt H, Schuh K, Skryabin BV, Movahedi K, Schweda F, Kuhn M.

Circulation. 2018 Jul 31;138(5):494-508. doi: 10.1161/CIRCULATIONAHA.117.033383.

PMID:
29626067
5.

Time-to-Furosemide Treatment and Mortality in Patients Hospitalized With Acute Heart Failure.

Matsue Y, Damman K, Voors AA, Kagiyama N, Yamaguchi T, Kuroda S, Okumura T, Kida K, Mizuno A, Oishi S, Inuzuka Y, Akiyama E, Matsukawa R, Kato K, Suzuki S, Naruke T, Yoshioka K, Miyoshi T, Baba Y, Yamamoto M, Murai K, Mizutani K, Yoshida K, Kitai T.

J Am Coll Cardiol. 2017 Jun 27;69(25):3042-3051. doi: 10.1016/j.jacc.2017.04.042.

6.

Tafamidis for the Treatment of Hereditary Transthyretin Amyloid Cardiomyopathy: A Case Report.

Fujita T, Inomata T, Kaida T, Iida Y, Ikeda Y, Nabeta T, Ishii S, Maekawa E, Naruke T, Koitabashi T, Kitamura E, Sekijima Y, Ako J.

Cardiology. 2017;137(2):74-77. doi: 10.1159/000455089. Epub 2017 Feb 3.

PMID:
28152524
7.

Temporal change of myocardial tissue character is associated with left ventricular reverse remodeling in patients with dilated cardiomyopathy: A cardiovascular magnetic resonance study.

Nabeta T, Inomata T, Fujita T, Iida Y, Ikeda Y, Sato T, Ishii S, Maekawa E, Mizutani T, Naruke T, Koitabashi T, Inoue Y, Ako J.

J Cardiol. 2017 Aug;70(2):185-191. doi: 10.1016/j.jjcc.2016.10.017. Epub 2016 Dec 13.

8.

Cardiac fibrosis detected by magnetic resonance imaging on predicting time course diversity of left ventricular reverse remodeling in patients with idiopathic dilated cardiomyopathy.

Ikeda Y, Inomata T, Fujita T, Iida Y, Nabeta T, Ishii S, Maekawa E, Yanagisawa T, Mizutani T, Naruke T, Koitabashi T, Takeuchi I, Ako J.

Heart Vessels. 2016 Nov;31(11):1817-1825. Epub 2016 Feb 3.

PMID:
26843195
9.

Higher hemoglobin A1c levels are associated with impaired left ventricular diastolic function and higher incidence of adverse cardiac events in patients with nonischemic dilated cardiomyopathy.

Ikeda Y, Inomata T, Fujita T, Iida Y, Kaida T, Nabeta T, Ishii S, Maekawa E, Yanagisawa T, Mizutani T, Naruke T, Koitabashi T, Takeuchi I, Ako J.

Heart Vessels. 2017 Apr;32(4):446-457. doi: 10.1007/s00380-016-0895-x. Epub 2016 Sep 26.

PMID:
27672077
10.

Clinical significance of endomyocardial biopsy in conjunction with cardiac magnetic resonance imaging to predict left ventricular reverse remodeling in idiopathic dilated cardiomyopathy.

Ishii S, Inomata T, Fujita T, Iida Y, Ikeda Y, Nabeta T, Yanagisawa T, Naruke T, Mizutani T, Koitabashi T, Takeuchi I, Ako J.

Heart Vessels. 2016 Dec;31(12):1960-1968. Epub 2016 Feb 26.

PMID:
26920939
11.

Prognostic significance of beta-blocker up-titration in conjunction with cardiac resynchronization therapy in heart failure management.

Nabeta T, Inomata T, Iida Y, Ikeda Y, Iwamoto-Ishida M, Ishii S, Naruke T, Mizutani T, Shinagawa H, Koitabashi T, Takeuchi I, Ako J.

Heart Vessels. 2016 Jul;31(7):1109-16. doi: 10.1007/s00380-015-0711-z. Epub 2015 Aug 8.

PMID:
26253941
12.

Time course of left ventricular reverse remodeling in response to pharmacotherapy: clinical implication for heart failure prognosis in patients with idiopathic dilated cardiomyopathy.

Ikeda Y, Inomata T, Iida Y, Iwamoto-Ishida M, Nabeta T, Ishii S, Sato T, Yanagisawa T, Mizutani T, Naruke T, Koitabashi T, Takeuchi I, Nishii M, Ako J.

Heart Vessels. 2016 Apr;31(4):545-54. doi: 10.1007/s00380-015-0648-2. Epub 2015 Feb 17.

PMID:
25686768
13.

Morphological changes in mitochondria during mechanical unloading observed on electron microscopy: a case report of a bridge to complete recovery in a patient with idiopathic dilated cardiomyopathy.

Ikeda Y, Inomata T, Fujita T, Iida Y, Nabeta T, Naruke T, Koitabashi T, Takeuchi I, Kitamura T, Miyaji K, Ako J.

Cardiovasc Pathol. 2015 Mar-Apr;24(2):128-31. doi: 10.1016/j.carpath.2014.10.003. Epub 2014 Oct 22.

PMID:
25453728
14.

Baseline cardiac magnetic resonance imaging versus baseline endomyocardial biopsy for the prediction of left ventricular reverse remodeling and prognosis in response to therapy in patients with idiopathic dilated cardiomyopathy.

Nabeta T, Inomata T, Iida Y, Ikeda Y, Iwamoto M, Ishii S, Sato T, Watanabe I, Naruke T, Shinagawa H, Koitabashi T, Takeuchi I, Nishii M, Inoue Y, Izumi T.

Heart Vessels. 2014 Nov;29(6):784-92. doi: 10.1007/s00380-013-0415-1. Epub 2013 Oct 4.

15.

Clinical significance of heart rate during acute decompensated heart failure to predict left ventricular reverse remodeling and prognosis in response to therapies in nonischemic dilated cardiomyopathy.

Ishii S, Inomata T, Ikeda Y, Nabeta T, Iwamoto M, Watanabe I, Naruke T, Shinagawa H, Koitabashi T, Nishii M, Takeuchi I, Izumi T.

Heart Vessels. 2014 Jan;29(1):88-96. doi: 10.1007/s00380-013-0335-0. Epub 2013 Mar 22.

PMID:
23519525
16.

End-tidal carbon dioxide concentration can estimate the appropriate timing for weaning off from extracorporeal membrane oxygenation for refractory circulatory failure.

Naruke T, Inomata T, Imai H, Yanagisawa T, Maekawa E, Mizutani T, Osaka T, Shinagawa H, Koitabashi T, Nishii M, Takeuchi I, Takehana H, Aoyama N, Izumi T.

Int Heart J. 2010 Mar;51(2):116-20.

17.

Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure.

Nishii M, Inomata T, Takehana H, Naruke T, Yanagisawa T, Moriguchi M, Takeda S, Izumi T.

J Am Coll Cardiol. 2008 Jun 17;51(24):2329-35. doi: 10.1016/j.jacc.2007.11.085.

18.

Clinical impact of adherence to guidelines on the outcome of chronic heart failure in Japan.

Ohsaka T, Inomata T, Naruke T, Shinagawa H, Koitabashi T, Nishii M, Takeuchi I, Takehana H, Izumi T.

Int Heart J. 2008 Jan;49(1):59-73.

19.

Prognostic significance of increased serum bilirubin levels coincident with cardiac decompensation in chronic heart failure.

Shinagawa H, Inomata T, Koitabashi T, Nakano H, Takeuchi I, Naruke T, Ohsaka T, Nishii M, Takehana H, Izumi T.

Circ J. 2008 Mar;72(3):364-9.

20.

11C-acetate and 18F-fluorodeoxyglucose positron emission tomography of pulmonary adenocarcinoma.

Kaji M, Nomori H, Watanabe K, Ohtsuka T, Naruke T, Suemasu K, Uno K.

Ann Thorac Surg. 2007 Jan;83(1):312-4.

PMID:
17184694
21.

Characteristics of advantages of positron emission tomography over computed tomography for N-staging in lung cancer patients.

Ebihara A, Nomori H, Watanabe K, Ohtsuka T, Naruke T, Uno K, Kuwahira I, Eguchi K.

Jpn J Clin Oncol. 2006 Nov;36(11):694-8. Epub 2006 Oct 26.

PMID:
17068084
22.

Prognostic significance of [(18)F]fluorodeoxyglucose uptake on positron emission tomography in patients with pathologic stage I lung adenocarcinoma.

Ohtsuka T, Nomori H, Watanabe K, Kaji M, Naruke T, Suemasu K, Uno K.

Cancer. 2006 Nov 15;107(10):2468-73.

23.

Obstructive subglottic granuloma after removal of a minitracheostomy tube.

Ohtsuka T, Nomori H, Watanabe K, Kaji M, Naruke T, Suemasu K.

Ann Thorac Cardiovasc Surg. 2006 Aug;12(4):265-6.

PMID:
16977296
24.

Beta2-Adrenergic agonists suppress rat autoimmune myocarditis: potential role of beta2-adrenergic stimulants as new therapeutic agents for myocarditis.

Nishii M, Inomata T, Niwano H, Takehana H, Takeuchi I, Nakano H, Shinagawa H, Naruke T, Koitabashi T, Nakahata J, Izumi T.

Circulation. 2006 Aug 29;114(9):936-44. Epub 2006 Aug 14.

PMID:
16908771
25.
26.

[F-18]Fluorodeoxyglucose positron emission tomography can predict pathological tumor stage and proliferative activity determined by Ki-67 in clinical stage IA lung adenocarcinomas.

Watanabe K, Nomori H, Ohtsuka T, Naruke T, Ebihara A, Orikasa H, Yamazaki K, Uno K, Kobayashi T, Goya T.

Jpn J Clin Oncol. 2006 Jul;36(7):403-9. Epub 2006 Jun 16.

PMID:
16782729
27.

A clinicopathological study of resected pulmonary nodules with focal pure ground-glass opacity.

Ohtsuka T, Watanabe K, Kaji M, Naruke T, Suemasu K.

Eur J Cardiothorac Surg. 2006 Jul;30(1):160-3. Epub 2006 May 24.

PMID:
16723239
28.

Isolated unilateral absence of a pulmonary artery treated by pneumonectomy in an adult: report of a case.

Ohtsuka T, Nomori H, Watanabe K, Kaji M, Ebihara A, Naruke T, Suemasu K.

Surg Today. 2006;36(6):525-7.

PMID:
16715422
29.

FDG-PET imaging for lymph node staging and pathologic tumor response after neoadjuvant treatment of non-small cell lung cancer.

Ohtsuka T, Nomori H, Ebihara A, Watanabe K, Kaji M, Naruke T, Suemasu K, Uno K.

Ann Thorac Cardiovasc Surg. 2006 Apr;12(2):89-94.

PMID:
16702929
30.

Positive imaging of thymoma by 11C-acetate positron emission tomography.

Ohtsuka T, Nomori H, Watanabe K, Naruke T, Suemasu K, Kosaka N, Uno K.

Ann Thorac Surg. 2006 Mar;81(3):1132-4.

PMID:
16488747
31.

11C-acetate positron emission tomography imaging for lung adenocarcinoma 1 to 3 cm in size with ground-glass opacity images on computed tomography.

Nomori H, Kosaka N, Watanabe K, Ohtsuka T, Naruke T, Kobayashi T, Uno K.

Ann Thorac Surg. 2005 Dec;80(6):2020-5.

PMID:
16305837
32.

Extended resection of lung cancer invading the left subclavian artery by using cardiopulmonary bypass.

Nomori H, Hirotani T, Watanabe K, Ohtsuka T, Naruke T, Suemasu K.

Ann Thorac Cardiovasc Surg. 2005 Jun;11(3):211-3.

PMID:
16030485
33.

False-positive findings on [18F]FDG-PET caused by non-neoplastic cellular elements after neoadjuvant chemoradiotherapy for non-small cell lung cancer.

Ohtsuka T, Nomori H, Watanabe K, Naruke T, Orikasa H, Yamazaki K, Suemasu K, Uno K.

Jpn J Clin Oncol. 2005 May;35(5):271-3. Epub 2005 May 9.

PMID:
15883125
34.

Intrapulmonary schwannoma.

Ohtsuka T, Nomori H, Naruke T, Orikasa H, Yamazaki K, Suemasu K.

Jpn J Thorac Cardiovasc Surg. 2005 Mar;53(3):154-6. Review.

PMID:
15828297
35.

[Benign metastasizing leiomyoma of the lung. Report of a case].

Ohtsuka T, Nomori H, Watanabe K, Naruke T.

Nihon Kokyuki Gakkai Zasshi. 2005 Feb;43(2):99-102. Japanese.

PMID:
15770941
36.

Radiofrequency ablation of pulmonary tumors and normal lung tissue in swine and rabbits.

Nomori H, Imazu Y, Watanabe K, Ohtsuka T, Naruke T, Kobayashi T, Suemasu K.

Chest. 2005 Mar;127(3):973-7.

PMID:
15764784
37.

Visual and semiquantitative analyses for F-18 fluorodeoxyglucose PET scanning in pulmonary nodules 1 cm to 3 cm in size.

Nomori H, Watanabe K, Ohtsuka T, Naruke T, Suemasu K, Uno K.

Ann Thorac Surg. 2005 Mar;79(3):984-8; discussion 989.

PMID:
15734419
38.

Large chest wall reconstruction using titanium micromesh and a pedicled latissimus dorsi musculocutaneous flap: report of a case.

Horio H, Ohtsuka T, Kubota Y, Hasegawa T, Nomori H, Naruke T, Suemasu K.

Surg Today. 2005;35(1):73-5.

PMID:
15622468
39.

Pulmonary metastasis 12 years after resection of thymoma with microscopic capsule invasion.

Nomori H, Watanabe K, Ohtsuka T, Naruke T, Suemasu K, Orikasa H, Yamazaki K.

Jpn J Clin Oncol. 2004 Oct;34(10):630-3. Review.

PMID:
15591463
40.

[False negative cases of F-18 fluorodeoxyglucose-positron emission tomography (FDG-PET) imaging in small lung cancer less than 3 cm in size].

Watanabe K, Nomori H, Ohtsuka T, Naruke T, Uno K.

Nihon Kokyuki Gakkai Zasshi. 2004 Sep;42(9):787-93. Japanese.

PMID:
15500145
41.
42.

Fluorine 18-tagged fluorodeoxyglucose positron emission tomographic scanning to predict lymph node metastasis, invasiveness, or both, in clinical T1 N0 M0 lung adenocarcinoma.

Nomori H, Watanabe K, Ohtsuka T, Naruke T, Suemasu K, Kobayashi T, Uno K.

J Thorac Cardiovasc Surg. 2004 Sep;128(3):396-401.

43.

[How can sentinel navigation surgery abbreviate mediastinal lymph node dissection for lung cancer?].

Nomori H, Ohtsuka T, Naruke T, Suemasu K.

Gan To Kagaku Ryoho. 2004 Jul;31(7):1125-9. Japanese.

PMID:
15272599
44.

Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images.

Nomori H, Watanabe K, Ohtsuka T, Naruke T, Suemasu K, Uno K.

Lung Cancer. 2004 Jul;45(1):19-27.

PMID:
15196730
45.

Superior sulcus lung cancer invading the ribs and brachial plexus successfully resected by modified trap-door thoracotomy after induction chemoradiotherapy.

Ohtsuka T, Nomori H, Horio H, Ebihara A, Naruke T, Suemasu K.

Jpn J Thorac Cardiovasc Surg. 2004 Apr;52(4):181-4.

PMID:
15141705
46.

Is major pulmonary resection by video-assisted thoracic surgery an adequate procedure in clinical stage I lung cancer?

Ohtsuka T, Nomori H, Horio H, Naruke T, Suemasu K.

Chest. 2004 May;125(5):1742-6.

PMID:
15136385
47.
48.
49.
50.

Surgery in locally advanced non-small cell lung cancer.

Naruke T.

Lung Cancer. 2003 Dec;42 Suppl 2:S11-5. Review. No abstract available.

PMID:
14644530

Supplemental Content

Loading ...
Support Center